Discovery Value Fund

Key Holdings

The portfolio is dominated by two "mega-cap" or large-cap growth leaders, with a smaller allocation to a biotechnology player.

• NVIDIA Corporation (NVDA): This is the undisputed core position, accounting for 65.40% of the total portfolio value ($36.63 million). Despite holding 196,000 shares, the fund reduced this stake by 12.5% during the quarter. This trimming suggests a strategy of taking profits or managing downside risk while maintaining a dominant exposure to the semiconductor and AI sector.
• DoorDash Inc (DASH): Representing 27.54% of the portfolio ($15.43 million), this holding was left unchanged during the quarter. It serves as the fund's second major growth engine, providing significant exposure to the logistics and food delivery sector. The stability of this position (57,000 shares) contrasts with the reduction in NVDA, highlighting the manager’s continued confidence in DASH at current valuations.
• Intellia Therapeutics Inc (NTLA): This is the smallest position at 7.05% ($3.95 million) and represents the fund's sole diversification outside of the technology sector. With 229,000 shares, this healthcare/biotech position provides high-risk/high-reward potential, likely acting as a diversifier that operates on a different catalyst set than the major tech holdings.